Literature DB >> 9682944

Hypogammaglobulinemia during antipsychotic therapy.

S Abe1, T Suzuki, T Hori, A Baba, H Shiraishi.   

Abstract

Hypogammaglobulinemia in a 22-year-old woman with brief psychotic disorder developed during antipsychotic therapy. Severe decreases in immunoglobulin IgM, IgG, and IgA concentration in serum were observed 4 months after the treatment with chlorpromazine (CPZ) and the other types of antipsychotics. Neither physical diseases nor family history for immunological disturbances was seen. No clinical symptoms in relation to immunological disturbances (i.e. infectious disease), were noted. Gammaglobulin levels in serum returned to a normal range after a replacement of chlorpromazine to timiperone. The hypogammaglobulinemia in the present case was considered to be due to the inhibition of gammaglobulin synthesis by CPZ.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9682944     DOI: 10.1111/j.1440-1819.1998.tb00983.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  2 in total

Review 1.  When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

Authors:  S Jolles; H Chapel; J Litzman
Journal:  Clin Exp Immunol       Date:  2017-01-30       Impact factor: 4.330

Review 2.  Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Authors:  Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles
Journal:  J Allergy Clin Immunol       Date:  2020-09       Impact factor: 10.793

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.